Where did you come up with the "30,000 suicides per year" figure?

I wonder if your five-to-seven per cent suicide rate among people with bipolar and schizophrenia includes iatrogenically caused suicide by drug reaction? I know the difference, having watched my son have 100% illness-related suicidality as a person with bipolar, and my daughter, who had drug-induced suicidality triggered by both Lexapro and Lamictal - with results lingering for months. We know there at least WERE a goodly number of SSRI suicides as the law firms have been kept busy, and some number of the same with the atypicals. I wonder how these numbers parse out...50% from the illness, 50% from the drugs?

I agree they scare us onto meds, and I think I'd sooner buy the 5-7% but the statistic I'm most curious about is attempted suicides. I know that's harder, almost impossible to track. The 30,000 a year if attempts were included would jump significantly I suspect. Triple perhaps or more? I mean I know a fair amount that weren't successful. Cough cough. That percentage might be more of a number that would scare people onto meds or to stay on them. I know I'm scared to come off my meds due to suicidal ideation that still persists off and on while on medications, but now it's manageable. The lithium has what like a 9 times reduction of chance of suicide?

Your guesstimate is pretty good. Here are data for suicide in patients with depression. The old number one still sees thrown around of 15% lifetime suicide risk is no longer accepted.

________________________________________
Citation 1. Unique Identifier 11097952

Authors Bostwick JM. Pankratz VS.

Institution Department of Psychiatry and Psychology, Mayo Clinic, Rochester, MN 55905, USA. bostwick.john@mayo.edu

Title Affective disorders and suicide risk: a reexamination.[see comment].

Comments
Comment in: Am J Psychiatry. 2001 Nov;158(11):1934-5; PMID: 11691715, Comment in: Am J Psychiatry. 2001 Nov;158(11):1934; author reply 1935; PMID: 11691716

Source American Journal of Psychiatry. 157(12):1925-32, 2000 Dec.

Abstract
OBJECTIVE: In 1970, Guze and Robins published a meta-analysis of suicide in patients with affective illness that inferred a lifetime risk of 15%. Since then, this figure has been generalized to all depressive disorders and cited uncritically in many papers and textbooks. The authors argue for an alternative estimate of suicide risk and question the generalizability of the Guze and Robins estimate. METHOD: The authors sorted studies obtained through a literature search that included data pertaining to suicide occurrence in affective illness into one of three groups: outpatients, inpatients, or suicidal inpatients. Suicide risks were calculated meta-analytically for these three groups, as well as for two previously published collections. RESULTS: There was a hierarchy in suicide risk among patients with affective disorders. The estimate of the lifetime prevalence of suicide in those ever hospitalized for suicidality was 8.6%. For affective disorder patients hospitalized without specification of suicidality, the lifetime risk of suicide was 4.0%. The lifetime suicide prevalence for mixed inpatient/outpatient populations was 2.2%, and for the nonaffectively ill population, it was less than 0.5%. CONCLUSIONS: The percentage of subjects dead due to suicide (case fatality prevalence) is a more appropriate estimate of suicide risk than the percentage of the dead who died by suicide (proportionate mortality prevalence). More important, it is well established that patients with affective disorders suffer a higher risk of suicide relative to the general population. However, no risk factor, including classification of diagnostic subtype, has been reliably shown to predict suicide. This article demonstrates a hierarchy of risk based on the intensity of the treatment setting. Given that patients with a hospitalization history, particularly when suicidal, have a much elevated suicide prevalence over both psychiatric outpatients and nonpatients, the clinical decision to hospitalize in and of itself appears to be a useful indicator of increased suicide risk.

________________________________________

that comes from the cdc/natl ctr for health stats.

You need to weigh suicides or attempted suicides while on meds against the self-damaging behavior (not necessary physical self-damage) that occurs with the subjects who are not meds but who ought to be. I define self-damaging behavior broadly to include bad judgment, failure to appreciate harm to oneself, etc.

Red Rover, I really don't think we can consider "bad judgement" to be a symptom of mental illness. Ditto "failure to appreciate harm." What about the smokers? Kentucky Fried Chicken diners? Gamblers? Fat people? People who drive too fast? Don't wear seatbelts? This is Big Pharma's wet dream: 100% of the population being diagnosable.